DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

ELLEN vs SUDARSHAN: Stock Comparison

ELLENBARRIE INDUS GASES L vs SUDARSHAN PHARMA INDUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

ELLENBARRIE INDUS GASES L shows faster revenue growth and a higher net margin, while SUDARSHAN PHARMA IND shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ELLEN leads 5; SUDARSHAN leads 3 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ELLENSUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹4,127 Cr
₹0 Cr
P/E RatioSUDARSHAN has the lower reading
34.53x
28.27x ✓
P/B RatioELLEN has the lower reading
3.94x ✓
4.11x
EPSELLEN has the higher reading
₹2.53 ✓
₹0.32
Book ValueContext only
₹69.33
₹6.14
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
SUDARSHAN has a lower P/E
28.27x vs 34.53x
P/B Ratio
ELLEN has a lower P/B
3.94x vs 4.11x
EPS
ELLEN has higher earnings per share
₹2.53 vs ₹0.32
Revenue Growth (TTM YoY)
ELLEN has faster revenue growth
6% vs 0%
EPS Growth (TTM YoY)
ELLEN has faster EPS growth
16.5% vs 0%
Qtr Sales Growth
SUDARSHAN has stronger quarterly sales growth
24.4% vs 15.8%
Qtr Profit Growth
SUDARSHAN has stronger quarterly profit growth
38.7% vs 1.96%
Net Margin
ELLEN has a higher net margin
30.53% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricELLENSUDARSHAN
SectorChemicals—
IndustryIndustrial Gases—

Price

MetricELLENSUDARSHAN
Live Price₹292.25₹32.71
Day Change-1.32%0.03%
Volume3.16 L92,985
52-Week High₹450.9₹39.3
52-Week Low₹175₹31.01
Distance from 52W High-35.19%-16.77%

Valuation

MetricELLENSUDARSHAN
Market Cap₹4,127 Cr₹0 Cr
P/E Ratio34.53x28.27x
P/B Ratio3.94x4.11x
EPS₹2.53₹0.32
Book Value₹69.33₹6.14
Dividend Yield0%0%

Growth

MetricELLENSUDARSHAN
Revenue Growth (TTM YoY)6%0%
EPS Growth (TTM YoY)16.5%0%
Qtr Sales Growth15.8%24.4%
Qtr Profit Growth1.96%38.7%

Profitability & Leverage

MetricELLENSUDARSHAN
ROE10.68%—
ROCE9.66%—
Net Margin30.53%0%
Operating Margin42.39%—
Debt to Equity0.18x—

Shareholding

As of Sep 2026 • change vs previous quarter
MetricELLENSUDARSHAN
Promoter Holding77.15%57.81%▼ 1.12 pp
FII Holding0.64%▼ 0.44 pp21.95%▲ 2.57 pp
DII Holding8.74%▼ 2.88 pp0%
Public Holding13.47%▲ 3.32 pp20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ELLENBARRIE INDUS GASES L and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.